{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:55:58Z","timestamp":1753890958945,"version":"3.41.2"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171182"],"award-info":[{"award-number":["82171182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1306305"],"award-info":[{"award-number":["2016YFC1306305"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Abnormal orexin-A levels in cerebrospinal fluid (CSF) have been identified in Alzheimer\u2019s disease (AD) and other neurodegenerative diseases. However, few studies have focused on Lewy body disease (LBD) and often with debatable outcomes. Thus, we performed this systematic review and meta-analysis to investigate orexin-A levels in LBD by incorporating data from different studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We gathered studies comparing orexin-A levels in patients with LBD and controls (including healthy controls and other dementia subtypes). In the initial search, 117 relevant articles were identified. After a selection process, seven studies, conducted in Japan, USA, Spain, Switzerland, France, Italy, and Netherlands, were chosen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 179 patients with LBD and 253 controls were included. Patients with LBD had significantly lower mean orexin-A CSF levels when compared with patients with AD [standard mean difference (SMD): \u22120.35, 95% confidence interval (CI): \u22120.70 to \u22120.00, Z = 1.96, P = 0.05], whereas mean orexin-A levels were significantly higher when compared with patients with frontotemporal lobar degeneration (FTLD) (SMD: 0.61, 95% CI: 0.23\u20130.99, Z = 3.12, P = 0.002). Orexin-A CSF levels in LBD patients were approximately equal to levels in healthy elderly individuals, whereas they were significantly decreased in LBD patients with excessive daytime sleepiness (EDS) (SMD: -0.15, 95% CI: -0.59 to 0.29, Z = 0.67, P = 0.50).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We showed that orexin-A levels in patients with LBD were not very different from those in normal elderly individuals, whereas they were lower than those in AD patients and higher than those in FTLD patients. The influence of hypersomnia on orexin-A levels should be carefully interpreted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:uri>, identifier CRD42021265900.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.765701","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T07:23:23Z","timestamp":1637133803000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Orexin-A in Patients With Lewy Body Disease: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Jinghuan","family":"Gan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhichao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuyan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11910-018-0835-5","article-title":"Lewy Body Disease: Clinical and Pathological \"Overlap Syndrome\" Between Synucleinopathies (Parkinson Disease) and Tauopathies (Alzheimer Disease)","volume":"18","author":"Foguem","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and Management of Dementia With Lewy Bodies: Fourth Consensus Report of the DLB Consortium","volume":"89","author":"Mckeith","year":"2017","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2016.01.007","article-title":"Rapid Eye Movement Sleep Disruption and Sleep Fragmentation are Associated With Increased Orexin-A Cerebrospinal-Fluid Levels in Mild Cognitive Impairment Due to Alzheimer\u2019s Disease","volume":"40","author":"Liguori","year":"2016","journal-title":"Neurobiol Aging"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141788","article-title":"Potential Role of Orexin and Sleep Modulation in the Pathogenesis of Alzheimer\u2019s Disease","volume":"211","author":"Roh","year":"2014","journal-title":"J Exp Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00835","article-title":"Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson\u2019s Disease","volume":"12","author":"Liu","year":"2018","journal-title":"Front Neurosci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm090","article-title":"Hypocretin (Orexin) Loss in Parkinson\u2019s Disease","volume":"130","author":"Fronczek","year":"2007","journal-title":"Brain J Neurol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1159\/000079749","article-title":"Normal CSF Hypocretin-1 (Orexin A) Levels in Dementia With Lewy Bodies Associated With Excessive Daytime Sleepiness","volume":"52","author":"Baumann","year":"2004","journal-title":"Eur Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41583-018-0097-x","article-title":"The Neurobiological Basis of Narcolepsy","volume":"20","author":"Mahoney","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/WNR.0b013e32833bfb7c","article-title":"Reduced Hypocretin (Orexin) Levels in Dementia With Lewy Bodies","volume":"21","author":"Lessig","year":"2010","journal-title":"Neuroreport"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/psyg.12618","article-title":"Association Between Cerebrospinal Fluid Orexin A Level and Severity of Rapid Eye Movement Sleep Behaviour Disorder in Dementia With Lewy Bodies","volume":"21","author":"Inagawa","year":"2021","journal-title":"Psychogeriatrics Off J Japanese Psychogeriatric Soc"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv104","article-title":"Parkinson\u2019s Disease Dementia: A Neural Networks Perspective","volume":"138","author":"Gratwicke","year":"2015","journal-title":"Brain J Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.3579","article-title":"Incidence of Dementia With Lewy Bodies and Parkinson Disease Dementia","volume":"70","author":"Savica","year":"2013","journal-title":"JAMA Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13195-018-0350-6","article-title":"Clinical Prevalence of Lewy Body Dementia","volume":"10","author":"Kane","year":"2018","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12883-021-02169-w","article-title":"Clinical Characteristics of Lewy Body Dementia in Chinese Memory Clinics","volume":"21","author":"Gan","year":"2021","journal-title":"BMC Neurol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2007.03.003","article-title":"Behavioral and Psychological Symptoms in Dementia With Lewy-Bodies (DLB): Frequency and Relationship With Disease Severity and Motor Impairment","volume":"46","author":"Borroni","year":"2008","journal-title":"Arch Gerontol Geriatrics"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp263","article-title":"Cerebrospinal Hypocretin, Daytime Sleepiness and Sleep Architecture in Parkinson\u2019s Disease Dementia","volume":"132","author":"Compta","year":"2009","journal-title":"Brain J Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0614-5","article-title":"Parkinsonism With Excessive Daytime Sleepiness: A Narcolepsy-Like Disorder","volume":"252","author":"Baumann","year":"2005","journal-title":"J Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Healthcare Interventions: Explanation and Elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"Bmj"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the Mean and Variance From the Median, Range, and the Size of a Sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Method"},{"key":"B20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000509585","article-title":"Cerebrospinal Fluid Hypocretin and Nightmares in Dementia Syndromes","volume":"11","author":"Trotti","year":"2021","journal-title":"Dementia Geriatric Cogn Disord Extra"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2006.08.004","article-title":"CSF Orexin Levels of Parkinson's Disease, Dementia With Lewy Bodies, Progressive Supranuclear Palsy And Corticobasal Degeneration","volume":"250","author":"Yasui","year":"2006","journal-title":"J Neurol Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a033118","article-title":"Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases","volume":"10","author":"Erkkinen","year":"2018","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.1.322","article-title":"The Hypocretins: Hypothalamus-Specific Peptides With Neuroexcitatory Activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00671.2002","article-title":"Attenuated Defense Response and Low Basal Blood Pressure in Orexin Knockout Mice","volume":"285","author":"Kayaba","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","article-title":"The Lewy Body in Parkinson\u2019s Disease and Related Neurodegenerative Disorders","volume":"47","author":"Wakabayashi","year":"2013","journal-title":"Mol Neurobiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000078194.53210.48","article-title":"Low Levels of Ventricular CSF Orexin\/Hypocretin in Advanced PD","volume":"61","author":"Drouot","year":"2003","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135480","article-title":"Increased Plasma Orexin-A Concentrations are Associated With the non-Motor Symptoms in Parkinson\u2019s Disease Patients","volume":"741","author":"Huang","year":"2021","journal-title":"Neurosci Lett"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3233\/jad-2012-111655","article-title":"Altered CSF Orexin and \u03b1-Synuclein Levels in Dementia Patients","volume":"29","author":"Wennstr\u00f6m","year":"2012","journal-title":"J Alzheimers Dis: JAD"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3233\/jad-190958","article-title":"Positive Association Between Cognitive Function and Cerebrospinal Fluid Orexin A Levels in Alzheimer\u2019s Disease","volume":"73","author":"Shimizu","year":"2020","journal-title":"J Alzheimer\u2019s Dis JAD"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00119","article-title":"Hypocretin and Brain \u03b2-Amyloid Peptide Interactions in Cognitive Disorders and Narcolepsy","volume":"6","author":"Dauvilliers","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"B31","article-title":"Orexin and Alzheimer\u2019s Disease","volume-title":"Behavioral Neuroscience of Orexin\/Hypocretin","author":"Liguori","year":"2017"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/science.1180962","article-title":"Amyloid-Beta Dynamics are Regulated by Orexin and the Sleep-Wake Cycle","volume":"326","author":"Kang","year":"2009","journal-title":"Sci (New York NY)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.2334","article-title":"Sleep Quality and Preclinical Alzheimer Disease","volume":"70","author":"Ju","year":"2013","journal-title":"JAMA Neurol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2013.12.036","article-title":"Hypocretin in Cerebrospinal Fluid is Positively Correlated With Tau and Ptau","volume":"561","author":"Deuschle","year":"2014","journal-title":"Neurosci Lett"},{"key":"B35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13195-014-0076-z","article-title":"Abnormal Daytime Sleepiness in Dementia With Lewy Bodies Compared to Alzheimer\u2019s Disease Using the Multiple Sleep Latency Test","volume":"6","author":"Ferman","year":"2014","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000008241","article-title":"Excessive Daytime Sleepiness and Topographic Expansion of Lewy Pathology","volume":"93","author":"Abbott","year":"2019","journal-title":"Neurology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2011.03.014","article-title":"Hypocretin (Orexin) Loss in Alzheimer\u2019s Disease","volume":"33","author":"Fronczek","year":"2012","journal-title":"Neurobiol Aging"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1177\/1533317513494453","article-title":"Reduced Orexin-A Levels in Frontotemporal Dementia: Possible Association With Sleep Disturbance","volume":"28","author":"\u00c7oban","year":"2013","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"B39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13041-019-0514-8","article-title":"Pharmacological and Chemogenetic Orexin\/Hypocretin Intervention Ameliorates Hipp-Dependent Memory Impairment in the A53T Mice Model of Parkinson\u2019s Disease","volume":"12","author":"Stanojlovic","year":"2019","journal-title":"Mol Brain"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/wco.0000000000000215","article-title":"\u03b1-Synuclein and Lewy Pathology in Parkinson\u2019s Disease","volume":"28","author":"Kalia","year":"2015","journal-title":"Curr Opin Neurol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00702","article-title":"Chemogenetic Modulation of Orexin Neurons Reverses Changes in Anxiety and Locomotor Activity in the A53T Mouse Model of Parkinson\u2019s Disease","volume":"13","author":"Stanojlovic","year":"2019","journal-title":"Front Neurosci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm097","article-title":"Hypocretin (Orexin) Cell Loss in Parkinson\u2019s Disease","volume":"130","author":"Thannickal","year":"2007","journal-title":"Brain J Neurol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/jad-122014","article-title":"Sleep in Frontotemporal Dementia is Equally or Possibly More Disrupted, and at an Earlier Stage, When Compared to Sleep in Alzheimer\u2019s Disease","volume":"38","author":"Bonakis","year":"2014","journal-title":"J Alzheimer\u2019s Dis JAD"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7455-z","article-title":"Cerebrospinal-Fluid Orexin Levels and Daytime Somnolence in Frontotemporal Dementia","volume":"261","author":"Liguori","year":"2014","journal-title":"J Neurol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.56.12.1749","article-title":"Normal Plasma Levels of Orexin A (Hypocretin-1) in Narcoleptic Patients","volume":"56","author":"Dalal","year":"2001","journal-title":"Neurology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nm0203-170","article-title":"Orchestrating Sleep-Wake Functions in the Brain","volume":"9","author":"Hajak","year":"2003","journal-title":"Nat Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4389","article-title":"Depressive Symptoms are Associated With Daytime Sleepiness and Subjective Sleep Quality in Dementia With Lewy Bodies","volume":"31","author":"Elder","year":"2016","journal-title":"Int J Geriatric Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.4265-05.2006","article-title":"Compensatory Changes in the Noradrenergic Nervous System in the Locus Ceruleus and Hippocampus of Postmortem Subjects With Alzheimer\u2019s Disease and Dementia With Lewy Bodies","volume":"26","author":"Szot","year":"2006","journal-title":"J Neurosci Off J Soc Neurosci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.765701\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T07:23:26Z","timestamp":1637133806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.765701\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":48,"alternative-id":["10.3389\/fendo.2021.765701"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.765701","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"article-number":"765701"}}